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Arterial revascularization with the right
gastroepiploic artery and internal mammary arteries
in 300 patients
From September 1989 to September 1992, the right gastroepiploic artery in combination with one or
both internal mammary arteries was used as a graft in 300 patients who underwent coronary artery
bypass grafting. The gastroepiploic artery was the primary choice in preference to the saphenous vein.
The study comprised 263 men and 37 women, ranging in age from 31 to 77 years (median age 59
years). Thirty-nine patients (13 %) underwent previous bypass procedures with autologous vein grafts.
In 17 patients (5.7%) the gastroepiploic artery was used as a single graft. In 150 patients (50%) the
gastroepiploic artery in conjunction with one internal mammary artery was used (in 6 patients
combined with a vein graft). In 133 patients (44.3%) the gastroepiploic artery was used with both
internal mammary arteries. Revascularization in nine patients (3 %) was combined with another cardiac
procedure; three aortic valve replacements, two mitral valve repairs, and four resections of a left
ventricular aneurysm. Ten patients died in the hospital (3.3 %; 70 % confidence limits 2.3 % to 4.8 %);
two of these patients had an infarction in the area revascularized by the gastroepiploic artery. At late
follow-up, 0.5 to 39 months (mean 14 months) after the operation, we found no mortality. One patient
with an occluded gastroepiploic artery graft underwent reoperation with the use of the right internal
mammary artery. One patient underwent percutaneous transluminal coronary angioplasty of the right
coronary artery after occlusion of the gastroepiploic artery. Elective recatheterization was done in 88
patients 1 to 25 months after operation (mean 10 months). Graft patency in gastroepiploic artery
grafts increased steadily from 77 % in the first semester of the study to 95 % in the fourth semester
and then equaled the patency of the internal mammary artery grafts (97 %), which was almost constant
during the whole period. We conclude that patency of the gastroepiploic artery was initially related to
a "learning curve" but eventually equaled that of the internal mammary artery grafts. Furthermore, the
gastroepiploic artery may well be the graft of choice in conjunction with the internal mammary
arteries. (J THORAC CARDIOVASC SURG 1994;107:1309-16)
Jan G. Grandjean, MD (by invitation), Piet W. Boonstra, MD, PhD (by invitation),
Peter den Heyer, MD (by invitation), and Tjark Ebels, MD, PhD (by invitation),
Groningen, The Netherlands
Sponsored by John W. Kirklin, MD, Birmingham, Ala.
Long-term patency of internal mammary artery
(IMA) grafts is superior to that of saphenous vein grafts
and is leading to an increasing use of this arterial bypass
From the Thoraxcentre of the University Hospital of Groningen, Gron-
ingen, The Netherlands.
Read at the Seventy-third Annual Meeting of The American Associa-
tion for Thoracic Surgery, Chicago, Ill., April 25-28, 1993.
Address for reprints: Jan G. Grandjean, MD, Department of Car-
diothoracic Surgery, University Hospital of Groningen, Oostersin-
gel 59, 9713 EZ Groningen, The Netherlands.
Copyright 1994 by Mosby-Year Book, Inc.
0022-5223/94 $3.00 + 0 12/6/53689
conduit.l>' However, both IMAs are usually not enough
for total arterial myocardial revascularization in three-
vessel coronary artery disease. Several reports'" have
suggested the right gastroepiploic artery (GEA) to be a
promising arterial bypass conduit as an adjunct to the
IMAs because of its equal size, free flow, and length"; its
comparable pharmacologic responses'? 11; and its low
susceptibility to atherosclerosis.?- 12, 13 Therefore, our
hypothesis was that the patency of the GEA graft would
be analogous to that of the IMA grafts. To determine the
patency of the grafts we performed elective angiography
in a subgroup of patients.
1309
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Fig. 1. Increase of arterial graft usage for primary coronary bypass operations. VEINgrajt only, Anastomoses made
with only saphenous vein grafts; IMA with VEINgraft, combination of IMA and saphenous vein graft; IMA (single
or both), operations with exclusivelyone or both IMAs; GEA, all primary bypass operations in which GEA was used;










30-35 36-40 41-45 46-50 51-55 56-M 61 ~5 66-70 71-75 76-80
age
Fig. 2. Distribution of patients with GEA graft by age (in years).
Patients and methods
Patient population. During the past 10 years there was an
increase in the use of arterial grafts and a strong decrease in the
use of only vein grafts for myocardial revascularization at our
institution. The number of reoperations was almost constant
during the past 4 years (Fig. I). Between September 1989 and
September 1992, 300 patients underwent myocardial revascu-
larization with the use of the GEA graft. The GEA graft was
the primary choice in preference to an autologous saphenous
vein graft. There were 263 men and 37 women with a median
age of 59 years (range 31 to 77 years; Fig. 2). Preoperative
patient characteristics are shown in Table I.
Chronic stable symptoms of angina were present in 194
patients (64.7%) and 106 patients (35.3%) had unstable symp-
toms. A previous myocardial infarction was present in 159
patients (53%) and 9 patients (6.3%) had more than one infarc-
tion. One previous coronary artery bypass grafting (CABG)
operation with saphenous vein grafts had been done in 39
patients (13%), 2 patients had two previous CABG operations,
and I patient had a previous aortic valve replacement operation.
The GEA was used as a solitary bypass graft in 17patients. The
GEA in combination with one IMA (149 left IMA grafts, I
right IMA graft, and 6 additional vein grafts) was used in 150
patients, and in 133 patients we used the GEA and both IMA
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PTCA. Percutaneous transluminal coronary angioplasty; NYHA. New York
Heart Association.
LAD. Left anterior descending; Cx, circumflex artery;RCA, right coronary artery;
RDP. right posterior descending; RPL. right posterolateral; LPL. left posterolat-
eral.
grafts. In 9 patients myocardial revascularization was combined
with another cardiac procedure: 3 aortic valve replacements ( I
aortic homograft), 2 mitral valve repairs, and 4 resections of a
left ventricular aneurysm (I combined with cryoablation for
ventricular tachycardia) .
A sequential arterial graft was used in 161 patients, a
sequential IMA graft in 137 patients (46%), and a sequential
GEA graft in 24 patients (8%). A free GEA graft was used in
only 2 patients. Elective angiography was done in the 88 patients
of the first I70 GEA operations who were willing to undergo this
procedure and who gave written informed consent. Angiograms
were done I to 25 months (mean 10 months) after operation .
Technique of the operation. The standard median sternot-
omy was extended 5 to 10cm caud ally. After one or both IMAs
were harvested the peritoneal cavity was opened.The GEA was
dissected with the use of two surgical clips (Hernoclip, medium ,
Edward Week & Co., Inc., Research Triangle Park , N .C.) on
each side branch to the stomach and omentum. The branches
were divided by electrocoagulation. The GEA was dissected
leftward to two thirds of the greater curvature of the stomach
and proximally to the pylorus. After systemic heparinization the
distal part of the GEA graft was divided and 0.5 ml of a solu-
tion of papaverine (0.1 mg jml) was gently injected into the dis-
tal part of the graft . The routing of the GEA to the pericardial
cavity was anterior to the pylorus and the left lobe of the liver.
An incision in the diaphragm was made anterior to the inferior
caval vein for routing the GEA to the pericardial cavity. The
coronary anastomoses were made with running 8-0 polypropy-
lene sutures . The pedicle was fixed to the epicardium by means
of two sutures (6-0 polypropylene) to the epicardium to avoid
kinking of the graft. The peritoneum was closed with a running
resorbable suture without a drain.
A standard cardiopulmonary bypass procedure was done by
a technique described elsewhere.!" Postoperative anticoagula-
tion treatment consisted of coumarin and dipyridamole 300 mg
daily.
Technique of angiography. Elective follow-up angiography
was done with the Judkins technique, by the femoral approach.
St andard Judkins 7F left and right coronary artery catheters, as
wellas pigtail catheters, were used for the native coronary artery
injections and the left ventricular angiogram. IMA catheters
were used for selective angiography of the left and right IMA
grafts .
A special technique was developed for angiography of the
GEA graft. The celiac trunk was cannulated via a lateral pro-
jection, with either a 7F Simmons type I or type 2 catheter (C.R .
Bard Ireland Ltd., Gallwa y, Ireland ) or a special GEA catheter
of our own design (built to specification by Cordis Europa NY,
Roden,The Netherlands). With use of the posteroanterior view,
a soft, steerable 0.035-inch guidewire (Terumo Corporation,
Tokyo, Japan) was advanced into the common hepatic artery or
subselectively into the gastroduodenal artery. The contr ast
catheters were advanced over these guidewires into the gas-
troduodenal artery or even into the origin of the GEA. Th is
technique allowed for selective hand injections of contrast fluid
and for excellent visualization of the GEA graft and its ana sto-
moses, as well as of the native coronary artery distal to th is
anastomosis with multiple project ions (Fig . 3). All angiograms
Fig. 3. Selective angiogram (posteroanterior view) of GEA. 1,
GEA catheter; 2, gastroduodenal artery; 3, GEA; 4, anastomo-





















































Table I. Patient characteristics
Table II. GEA anastomoses
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Table III. Mortality by category ofbypass operation




























• Additional cardiac procedure included aortic valve replacement in three patients; mitral valve repair in two; and left ventricular aneurysm resection in four.
wererecorded on cinefilm at 12.5 to 25 frames per second and
reviewed by two independent observers. Anastomoses were
considered to be closed, unless proved patent.
Statistical analysis. Data were gathered in contingency
tables.Logistic regression analysis wasusedto determine incre-
mental risk factors for death and graft occlusion. A p valueof
0.05 or lesswas considered to be significant.
Results
Between September 1989 and September 1992, 2025
primary CABG operations and 121 repeat CABG oper-
ations were done at our institution. In the primary CABG
operations the GEA was used in 261 patients (13%) and
in the repeat CABG operations the GEA was used in 39
patients (32%). The GEA was always long enough for
grafting all coronary artery branches on the diaphrag-
matic aspect ofthe heart. A total of894 anastomoses (561
IMA, 325 GEA, 8 vein) were made with the use of 716
arterial grafts and 6 vein grafts. A mean number of 2.4
grafts per patient and 3.0 anastomoses per patient were
performed. One anastomosis was done with 276 GEA
grafts, two anastomoses with 23 GEA grafts, and three
anastomoses with 1GEA graft, resulting in a mean of 1.1
anastomosis per GEA graft (Table 11). The mean num-
ber of anastomoses of the IMA grafts was 1.3.
A total of 10 patients (3.3%) died, all in the hospital
(Table III). The mortality rate was higher in the group
of patients with reoperations (4 of 39 patients, 10%;CL*
5% to 18%) and in the group with combined operations
(1 of 9 patients, II %; CL I% to 33%) than in the group
with primary operations (5 of 252 patients, 2.0%; CL
1.1% to 3.4%). Mortality in the reoperation group was
associated with an inferior infarction in two patients,
which was the site where the GEA was used as a bypass
graft. One patient died as a result of an embolizing
thrombus from an old vein graft, and one patient had a
rupture of an aneurysm of the abdominal aorta.
In the group of 252 primary CABG operations five
patients died (2.0%; CL 1.1% to 3.4%). Three patients
died of brain infarctions, one patient died of a myocardial
infarction from an atheromatous aorta, and one patient
*Confidence limits.
died of an anterior infarction after the left anterior
descending (LAD) branch was not found.
In the nine patients who underwent a CABG operation
combined with another cardiac procedure there were
three aortic valve replacements, two mitral valve repairs,
and four left ventricular aneurysm resections. One of
these patients died (11%; CL I% to 33%). In this patient,
a 69-year-old man, wedid a CABG operation with the left
IMA to a diagonal branch and the LAD, the GEA graft
to the posterior descending branch, and an aortic valve
replacement with a homograft. One week after the oper-
ation there were signs of pneumonia and 2 days later signs
of mediastinitis. The patient died of multiorgan failure
after 45 days. At autopsy the grafts were patent. There
was no late mortality.
Four patients underwent reoperation, twice because of
graft occlusion of, respectively, the left IMA and the GEA
graft, once because of a new stenosis in the LAD, and once
because of mitral and tricuspid valve regurgitation after
endocarditis (Table IV). A postoperative percutaneous
transluminal coronary angiography (PTCA) procedure
was done in three patients; one patient underwent a reop-
eration with a left IMA graft to the LAD and a GEA
graft to the posterior descending branch. Eight months
after the second operation there was a severe stenosis in
the old venous jump graft to the circumflex artery treat-
ed by PTCA. A PTCA of the right coronary artery was
done in a patient with an occluded GEA graft to this ves-
sel. A PTCA of the circumflex artery was done in a
patient with a sequential left IMA graft and a GEA graft
to the right coronary artery, which was occluded. The
circumflex branch had a new stenosis, whereas there was
no longer any significant stenosis in the right coronary
artery.
Mediastinitis was encountered in two patients, once in
a patient who was operated on with the use of the three
arterial grafts and once in the patient mentioned before,
who was operated on for an aortic valve stenosis with a
homograft and two arterial grafts. Gastrointestinal bleed-
ing occurred only once and was treated conservatively.
There were no late abdominal symptoms at follow-up.
Myocardial infarction was encountered in 10 patients
The Journal of Thoracic and
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Fig. 4. Patency as shown by angiography after 10 months (mean).
(3.3%) on the basis of clinical symptoms, electrocardio-
graphic changes, and increased specific enzyme levels.
Rethoracotomy for persistent bleeding was necessary in
24 patients (8%). In only two cases was this caused by
bleeding from the pedicle of the G EA graft.
Angiography was done in 88 patients and the overall
patency of the GEA anastomoses was 84.5%, whereas the
patency of IMA anastomoses was 97%. One hundred
three anastomoses were visualized of 88 G EA grafts. We
found that the patency of the 103 GEA anastomoses of
patients operated on in the first semester of the study was
77% (n = 31). However, the patency increased to 80%
(n = 21) in patients operated on in the second semester,
to 85% (n = 27) in patients of the third semester, and to
95% (n = 24) in patients of the fourth semester
(p = 0.037). In contrast to the increasing patency rate of
the GEA throughout the study period, we found a rela-
tively constant patency rate in the IMA anastomoses of
93% to 98% (Fig. 4). Among the 88 angiograms, 112
IMA grafts (78 left IMAs; 34 right IMAs) and 154 IMA
anastomoses were visualized.
The angiographic patency rates of IMA grafts and
GEA grafts in relation to the grafted coronary vessels are
shown in Table V. Both left and right IMA grafts had a
very high patency rate of between 94% and 100% when
anastomosed to the LAD or circumflex artery. The over-
all patency of the GEA graft was somewhat lower when
the GEA was anastomosed to the right coronary artery
(88%) and to the circumflex artery (74%).
Logistic regression analysis produced pump time and
reoperation as incremental risk factors for death. Incre-
mental risk factors for occlusion of at least one GEA
















MVP, Mitral valve plasty; TVP, tricuspid valve plasty.
Discussion
. Long-term survival after CABG operation with the use
of IMA grafts is better than that with the use of autolo-
gous saphenous vein grafts, in particular in the young
patient.v ' This is because of the low susceptibility for
atherosclerosis and the superior patency of the IMA
grafts. However, both IMA grafts are usually not enough
for total arterial myocardial revascularization in three-
vessel coronary artery disease.
Several authors have reported that the right GEA is a
promising alternative bypass conduit for the saphenous
vein.4.8 Suma, Fukumoto, and Takeuchi? found that the
in situ GEA has a suitable diameter for CABG and is long
enough to reach coronary arteries on the inferior ventric-
ular wall even distally. Anastomoses of the in situ GEA
graft with the LAD and circumflex arteries were also
made. O'Neil and associates10 concluded from their study
concerning the endothelial function of the GEA that the
I 3 I 4 Grandjean et al.
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The following factors were part of regression analysis: sex, age, preoperative New
York Heart Association classification, preoperative infarction, weight, year of
operation, surgeon, aortic occlusion time, pump time, additional cardiac proce-
dure. reoperation, mediastinitis, and atrial fibrillation. {3, Risk factor coefficient;
SE, standard error of mean; p, level of significance.
abdominal aorta aneurysm (n = I), and brain infarction
(n = 3). At late follow-up(0.5 to 39 months) we found no
late mortality. In addition, use of the GEA did not lead
to an increase in perioperative morbidity for CABG
operations. Two of the 24 rethoracotomies for persistent
bleeding were necessary because of bleeding of the
gastroepiploic pedicle, located in the pericardial cavity.
Moreover, we encountered only one gastrointestinal
bleeding episode, which could be treated conservatively.
Mediastinitis, a severe complication after CABG opera-
tion, was encountered twice.
Angiograms of the GEA grafts were obtained at post-
operative intervals ranging from 3 weeks to 25 months
(mean 10 months). We found in patients operated on in
the first semester of the study that the patency rate of the
GEA (77%) was significantly lower than that ofthe IMA
grafts. However, the patency rate of the GEA graft
increased steadily to 95% in the fourth semester and vir-
tually equaled that of the IMA (97%), indicating a
"learning curve" (p = 0.037). This finding stresses the
fact that some training by skilled surgeons is advisable.
Additionally, pump time (operative complexity) and
female gender were risk factors for occlusion. A specific
cause for the higher occlusion rate in women is as yet
unclear.
Encouraged by these results we use the GEA graft now
as the first adjunct to the IMAs evenin the elderiypatient.
Our oldest patient who receiveda GEA graft was 77 years
old. An absolute contraindication to the use of the GEA
as a graft is a previous gastric resection, whereas severe
obesity, abdominal aortic operation, and previous chole-
cystectomy are relative contraindications. In patients
with insulin-dependent diabetes the use of one IMA graft
in combination with a GEA graft is probably preferable
to the use of two IMA grafts, which is associated with a
high risk of sternal infections.7
Table V. Patency rate according to grafted coronary
artery
LAD Cx RCA
LIMA 98% (85) 100%(32)
RIMA 100%(17) 94% (17) 100%( 2)
GEA 100% (I) 74% (27) 88% (75)
FLIMA 100% (2)
Vein 50% (2)
Patency rate is distributed according to the coronary artery that was grafted.
Number of studied anastomoses is given between parentheses. LAD, Left anteri-
or descending; Cx, circumflex artery; RCA, right coronary artery; LIMA, left
IMA; RIMA, right IMA; F LIMA, free left IMA; Vein, saphenous vein graft.
human GEA possesses the necessary properties to be a
successful arterial bypass graft. Moreover, the GEA is
pharmacologically comparable with the IMA and exhib-
its similar resistance against developing atherosclerosis.
In a report from our institution dealing with endothelial
responses ofGEA and IMA to vasoactive substances, we
found a resemblance of relaxations induced by meth-
acholine and sodium nitrite in the GEA and IMA, sug-
gesting a similar activation and behavior of the L-argin-
ine pathway in both arteries. I I This would indicate
that the protective role of the endothelium, which con-
tributes to the high patency rate of IMAs, is also appli-
cable to GEAs. This prompted us to use the GEA as an
alternative arterial conduit to create complete arterial
revascularization in three-vessel coronary artery disease.
Our hypothesis was that the patency rate of the GEA
bypass conduit would be analogous to that of mammary
arteries.
In this ongoing study we found that harvesting of the
GEA was less tedious, easier, and of shorter duration than
that of the IMA. In contrast to the experience of others?
the dissection of the IMA and of the GEA is done in our
institution by the same surgeon. However, we agree with
Lytle and associates'' that the use of the GEA increases
the difficulty and complexity of the operation. Neverthe-
less, the use of the GEA has not led to a significant
increase in our perioperative mortality for CABG oper-
ations. Overall, 10patients (3.3%; 70% CL 2.3%to 4.8%)
died in the hospital. This mortality was mainly because of
a relatively high mortality rate in the reoperative cases (4
out of 39, 10%), which was also reflected in the incre-
mental risk factors for death. Pump time reflecting the
complexity of the operation was an incremental risk fac-
tor independent of reoperation. Only in two patients was
mortality related to an inferior infarction, the area revas-
cularized by the GEA; in the other patients mortality was
related to anterior infarctions (n = 2), atheromatous aor-
ta (n = I), multiorgan failure (n = I), rupture of an
Table VI. Logistic regression analysis
{3 SE
Incremental risk factor for death
Reoperation 1.5321 0.7047
Total pump time 0.0179 0.0059
Intercept -5.6431 0.8295
Incremental risk factor for GEA graft occlusion
Female gender 0.8412 0.4642
Total pump time 0.0172 0.0078
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We conclude that graft failure of the GEA was initial-
ly related to a "learning curve" but eventually equaled
that of the IMA grafts. Furthermore, the GEA may well
be the graft of choice in conjunction with the IMAs.
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Discussion
Dr. George Cimochowski (Wilkes-Barre. Pa.). Dr. Grand-
jean and his colleagues are to be complimented on an excellent
experience that demands superb surgical judgment and tech-
nique in a large series of patients.
We have attempted at Wilkes-Barre General Hospital to do
a similar thing over the past 2 years. Our experience is such that
there were 907 isolated CABG operations done over 2 years. We
used only veins in 2.5%. The majority of patients had either a
single IMA or double IMA or a combination of artery and veins
used for the grafts. In 22% of the patients we were able to use
only arterial grafts, which represents 200 out of 907 patients.
We attempted to do only arterial grafts in all patients less than
60 years of age, selectively from 60 to 75 years, and in patients
older than 75 only when they had no other conduits.
We had pretty much the same experience as Dr. Grandjean
and his group. Our patients had a mean age of 56.7 years. We
did 2.82 arterial grafts per patient. Our mortality rate was 2%
with a 0.5% rate of sternal wound infection. Our most common
combination of conduits was bilateral IMAs and epigastric
artery in about 40% of the patients.
We did mostly three-vessel grafts: three arterial grafts were
done in about 40% of patients. Second most common was two-
vessel grafting, and there was a smattering of other types of
operations with sequential grafts.
The last point is that because we use the epigastric artery
almost exclusively to the circumflex system, we attempted to put
the right IMA in situ to the posterior descending coronary
artery. Overall we reached the posterior descending coronary
artery in about 600/0 of the patients, but in the past 6 months we
were able to do this in 81%.
I have three questions for the authors. First, what was the
percentage of arterial grafts you did over the past 3 years?
Second, do you have any results of physiologic testing, such
as stress testing, to show that in fact ischemia has been relieved
with this procedure?
Last, and this is a politically difficult question, in European
literature and obviously in your group, arterial operation is used
much more than on this continent. I wonder if you could com-
ment as to why?
Dr. John B. Flege, Jr. (Cincinnati. Ohio). In the continuing
quest for other conduits for coronary artery bypass, particular-
ly for patients who have had multiple previous operations, I
turned to Sobatta's excellent illustrations. They show that the
left gastric artery early in its course is adjacent to the diaphragm
and only a few millimeters from the inferior surface of the heart.
It would appear to be a satisfactory graft for coronary artery
bypass.
A postoperative arteriogram shows the left gastric artery
anastomosed to the posterior descending coronary artery. Its
course is very short, and it lies out of harm's way in the event
that the patient must have an upper abdominal operation.
I would like to ask the authors if any of their patients have
had subsequent upper abdominal operations in which the GEA
could be harmed.
Dr. Hisayoshi Suma (Tokyo. Japan). When I looked at my
initial 300 experiences with the GEA graft, the mean age of the
patients was 59 years and the majority of patients had triple-
vessel disease. The number of total distal anastomoses was 3.1
and the mean number of arterial graft anastomoses was 2.2 in
combination with the IMA in 96% of the patients and the infe-
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rior epigastric artery quite recently in 14 patients. There were
seven early and four late deaths. A new Qwave was noted in five
patients. On postoperative angiography, the patency of the GEA
graft was 94% at both early and late (up to 5 years) restudy. I
agree with your conclusion that the GEA is a useful conduit in
CABG operations.
I have two questions. First, how did the authors handle the
patent GEA graft at the time of reoperation ? I had one case with
this situation, with a patent GEA to the right coronary artery,
and the target of the reoperation was the LAD. I approached
this with a left thoracotomy very successfully.
Second, how many patients underwent abdominal operation
after this kind of operation, and how did you handle this?
Dr. O. Jegaden (Lyon, France). I have used the GEA in 240
patients without a vein graft and without early mortality. Its use
was associated with one IMA in 100 patients and with both
IMAs in 140 patients.
In the first 100 patients, the graft patency rate was 96% for
the GEA and 99% for the IMA. I think that this technique can
be done as a normal procedure with a low mortality. In my
experience this technique is actually done in 90% of patients.
However, wecannot forget that theobjectiveofthis technique
is to improve long-term results in graft patency freedom from
complications, and survival. I think that in some patients this
technique may increase the operative risk as in patients older
than 75 years and particularly in patients with severe left ven-
tricular dysfunction and ejection fractions less than 30% per-
cent, who need immediate and optimal flow in the graft.
My question is this: What are the limits ofthis technique and
in which patients do you not perform this technique?
Dr. Frank C. Spencer (New York, N'Y}. I have one ques-
tion. Your slides showed a very striking learning curve, inas-
much as the good results rose from 77% to higher than 90% over
3 years. Please tell us what you learned.
Dr. Grandjean. Dr. Cimochowski, over the past 3 years we
operated on about 2000 primary CABG cases. We used the vein
graft in 8% of the cases, a combination of one IMA graft and
a vein graft in 55%, and in nearly 400/0 of the cases only arterial
grafts including the GEA graft. We try to increase the use of
arterial grafts in preference to the vein graft.
In nearly all the patients a stress test is done by their own
cardiologist and there is a relief of ischemia in the inferior wall
where a GEA graft is used, as there is a relief when the IMA
grafts are used.
During our training we start with bypass operations in which
the left IMA is anastomosed to the anterior wall of the heart.
At the end of the training the surgeon is skilled in using IMAs
and the next step is the use of other arterial grafts such as the
GEA. We are rather liberal in the use of new and, we think,
better operative techniques.
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Dr. Flege, we have not used the left gastric artery yet, but it
seems to be a promising arterial conduit. Your next question
dealt with upper abdominal operations after a CABG operation
in which the GEA was used. You are right when you say that
this can cause some problems. All the patients who are operat-
ed on with the use of a GEA graft have to know that they have
been operated on in the abdomen, and we give them a drawing
with the position of the grafts. In this series of 300 patients we
had one patient who underwent urgent laparotomy after rupture
of an aneurysm of the abdominal aorta. We stayed "far" away
from the GEA graft and its origin. Unfortunately this patient
died of abdominal complications. For cholecystectomy a more
lateral transverse incision is then preferable.
Dr. Suma, in this series four patients underwent reoperation.
One patient with patent left IMA and GEA grafts underwent
reoperation for mitral and tricuspid regurgitation after pan-
carditis. This operation was done with normothermic bypass and
with a beating heart. There was one patient with an occluded
GEA graft who underwent a reoperation with a free right IMA
to the right posterior descending coronary artery. One patient
who had a new stenosis in the LAD had an urgent reoperation
with a vein graft to the LAD after an angioplasty procedure
failed. The last patient had a occluded left IMA, and a right
IMA was then anastomosed to the LAD. The GEA could eas-
ily be clamped during cardioplegic arrest.
In this series of 300 patients only one patient underwent an
abdominal operation. This was the patient who was operated on
for rupture of an aneurysm of the abdominal aorta.
Dr. Jegaden, as you mentioned, there will always be some
contra indications for the use of so many arterial grafts. I giveall
my patients at least one arterial graft, even in patients with bad
ventricular function. My opinion is that if you operate on these
patients with vein grafts and after a few years this vein graft
becomes occluded, there will be hardly a surgeon who will do a
reoperation on these patients. My philosophy is to give the
patients the best chance the first time, with arterial grafts.
Dr. Spencer, we did have a learning curve and in the begin-
ning all the surgeons in our group tried to use the GEA for
revascularization. After a while only two surgeons were subse-
quently using the GEA and they operated on 70%of the patients
in this series. In the beginning anastomoses were made with the
more distal part of the GEA and now we shorten the GEA until
it is just long enough so that the diameters for the anastomoses
are wider. We also used the GEA as a jump graft between
branches ofthe right coronary artery and the circumflex artery,
and at follow-up angiography many of the distal and thinner
parts of the GEA were occluded. Now we use the GEA for the
inferior part of the heart and the IMAs for the posterior and
anterior parts of the heart.
